Wilson's Disease
25
8
11
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 25 trials
100.0%
+13.4% vs benchmark
12%
3 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (25)
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Cardiac Involvement in Wilson's Disease
Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
Subclinical Myocardial Dysfunction in Children With Wilson's Disease
International Wilson's Disease Patient Registry (iWilson Registry)
Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease
Exchangeable and Relative Exchangeable Copper as an Alternative to 24-Hour Urinary Copper in Wilson's Disease Monitoring
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride
Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map
Endocrine Dysfunction in Pediatric Wilson's Disease
WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Gandouling in the Treatment of Wilson's Disease
Early Detection of Cardiac Affection in Patients of Wilson's Disease
sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis